Werkgroep Cardiologische centra Nederland English

Trimetazidine (Klaar)

Prevention of angina following percutaneous coronary intervention with trimetazidine MR. An international, multicentre, randomised, double-blind, placebo-controlled study  in patients treated for 1 to 2 years.

Middel
trimetazidine MR Vastarel
Populatie
acuut coronair syndroom
Fase
fase III
Jaar aanvang
2011

Studiedirecteur

drs. C. van der Zwaan (Cardioloog)
Tiel, Rivierenland